Immunological and Clinical Analysis of Experimental Heat Shock Protein-Induced Uveitis

实验性热休克蛋白诱导葡萄膜炎的免疫学和临床分析

基本信息

  • 批准号:
    11671752
  • 负责人:
  • 金额:
    $ 2.11万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2001
  • 项目状态:
    已结题

项目摘要

We have already demonstrated that the heat shock protein (HSP) T cell peptide determinants which specifically stimulate T cells from patients with ocular type Behcet's disease (BD) are capable of both inducing uveitis and stimulating lymphocyte proliferation in rats. In the present study, mycobacterial HSF 65 kD and those peptides were injected into Lewis rats, and IgG and IgA antibodies (Abs) were measured using an enzyme-linked immunosorbent assay (ELISA). Serum collected 21 days after immunization of HSP peptides from rats that developed uveitis showed significantly higher IgG Ab levels to peptide 311-326 and 336-351 than did serum samples collected from rats without uveitis. Significant elevation of levels of IgA Abs in rats that developed uveitis was also observed in rats immunized with 111-125, 311-326 and 336-351. 1. In rats injected with HSP 65 kD, the IgG Ab levels to peptide 111-125, 154-172 and 311-326 showed a considerable increase and the IgA Ab level to peptide 311-326 also showed a marked elevation. Marked inhibition of IgG Ab binding to HSP 65 kD by peptides 111-125, 154-172, 311-326 and 336-351 and of IgA Ab binding by peptides 311-326 and 336-351 were observed in rats immunized with HSP 65 kD. These results suggest that the epitopes responsible for ocular disease development and antibody production in rats injected with HSP 65 kD might be similar or identical to those that are most immunogenic for T cells from patients with ocular type BD, and that IgA Abs play a similar or more critical and important role compared with IgG Abs in the development and progression of HSP-induced uveitis, and that they can be used as markers of disease activity.
我们已经证明,热休克蛋白(HSP)的T细胞肽决定簇,特异性刺激T细胞从患者眼型白塞病(BD)能够诱导葡萄膜炎和刺激淋巴细胞增殖的大鼠。在本研究中,分枝杆菌HSF 65 kD和这些肽注射到刘易斯大鼠,并使用酶联免疫吸附测定(ELISA)测定IgG和伊加抗体(Abs)。HSP肽免疫后21天从发生葡萄膜炎的大鼠收集的血清显示出比从没有葡萄膜炎的大鼠收集的血清样品显著更高的针对肽311-326和336-351的IgG Ab水平。在用111-125、311-326和336-351免疫的大鼠中也观察到发生葡萄膜炎的大鼠中伊加Ab水平显著升高。1.注射HSP 65 kD的大鼠,对111-125、154-172和311-326肽的IgG抗体水平明显升高,对311-326肽的伊加抗体水平也明显升高。在HSP 65 kD免疫的大鼠中观察到肽111-125、154-172、311-326和336- 351显著抑制IgG Ab与HSP 65 kD的结合,肽311-326和336 -351显著抑制伊加Ab与HSP 65 kD的结合。这些结果表明,在注射HSP 65 kD的大鼠中负责眼部疾病发展和抗体产生的表位可能与来自眼部型BD患者的T细胞的最具免疫原性的表位相似或相同,并且与IgG Ab相比,伊加Ab在HSP诱导的葡萄膜炎的发展和进展中起相似或更关键和重要的作用,并且它们可以被用作疾病活动的标记。

项目成果

期刊论文数量(34)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kadonosono K, Yazama F, Itoh N, Uchio E, Nakamura S, et al.: "Treatment of retinal detachment resulting from myopic macular hole with internal limiting membrane removal"American Journal of Ophthalmology. 131. 203-207 (2001)
Kadonosono K、Yazama F、Itoh N、Uchio E、Nakamura S 等人:“通过内界膜去除治疗近视性黄斑裂孔引起的视网膜脱离”美国眼科杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Uchio E, et al: "Tear levels of interferon-r, interlenbin-2, interlenbin-4 and interlenbin-5 in patients with VKC, AKC and AC."Clinical and Experimental Allergy. 30. 109-109 (2000)
Uchio E 等人:“VKC、AKC 和 AC 患者的干扰素-r、interlenbin-2、interlenbin-4 和 interlenbin-5 的泪液水平。”临床和实验过敏。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
内尾英一、大野重昭: "月刊眼科診療プラクティス 感染の関与が疑われるぶどう膜炎"文光堂. 137 (1999)
Eiichi Uchio、Shigeaki Ohno:“每月眼科实践:怀疑与感染有关的葡萄膜炎”Bunkodo 137(1999)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kadonosono K, Yazama F, Itoh N, Uchio E, Nakamura S, et al: "Treatment of retinal detachment resulting from myopic macular hole with internal limiting membrane removal"American Journal of Ophthalmology. 131. 203-207 (2001)
Kadonosono K、Yazama F、Itoh N、Uchio E、Nakamura S 等人:“通过内界膜去除治疗近视性黄斑裂孔引起的视网膜脱离”美国眼科杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Uchio E, Kasonosono K: "Are airbags are a risk for patients after radial keratotomy ?"British Journal of Ophthalmology. 85. 640-642 (2001)
Uchio E、Kasonosono K:“安全气囊对放射状角膜切开术后的患者有风险吗?”《英国眼科杂志》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

UCHIO Eiichi其他文献

UCHIO Eiichi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('UCHIO Eiichi', 18)}}的其他基金

Evaluation of new medical treatment and its clinical development for adenoviral ocular infectious diseases
腺病毒眼部感染性疾病新药治疗评价及临床进展
  • 批准号:
    24592686
  • 财政年份:
    2012
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Research on the development of the new medical treatment and its clinical use in adenoviral ocular infection
腺病毒眼部感染新药开发及临床应用研究
  • 批准号:
    21592269
  • 财政年份:
    2009
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of novel agent for adenoviral ocular infection based on virological analysis
基于病毒学分析的腺病毒眼部感染新药的开发
  • 批准号:
    18591944
  • 财政年份:
    2006
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Immunological analysis of dendritic cell-osteopontin system in the remodeling of serious ocular allergy
树突状细胞-骨桥蛋白系统在严重眼部过敏重塑中的免疫学分析
  • 批准号:
    15591869
  • 财政年份:
    2003
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Risk of COVID-19 Exacerbation in Novel Experimental Model of Chronic Aspiration Pneumonia
慢性吸入性肺炎新型实验模型中 COVID-19 恶化的风险
  • 批准号:
    22K16454
  • 财政年份:
    2022
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Basic research for the widespread use of non-heart-beating donor uterus transplantation (animal experimental model)
无心跳供体子宫移植广泛应用的基础研究(动物实验模型)
  • 批准号:
    22K09626
  • 财政年份:
    2022
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of experimental model for surface antigens of human malaria parasite
人类疟原虫表面抗原实验模型的建立
  • 批准号:
    22K19434
  • 财政年份:
    2022
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Experimental model of depression in aging: anxiety, inflammation, and reward mechanisms
衰老过程中抑郁症的实验模型:焦虑、炎症和奖励机制
  • 批准号:
    10371312
  • 财政年份:
    2022
  • 资助金额:
    $ 2.11万
  • 项目类别:
Experimental model of depression in aging: anxiety, inflammation, and reward mechanisms
衰老过程中抑郁症的实验模型:焦虑、炎症和奖励机制
  • 批准号:
    10584612
  • 财政年份:
    2022
  • 资助金额:
    $ 2.11万
  • 项目类别:
Development of a new experimental model of chronic focal cerebral ischemia and elucidation of hyperperfusion following vascular reconstruction
慢性局灶性脑缺血新实验模型的开发及血管重建后过度灌注的阐明
  • 批准号:
    22K09226
  • 财政年份:
    2022
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of a novel experimental model of retinal pericyte deletion for accelerating the development of therapeutic agents for diabetic retinopathy
建立新型视网膜周细胞缺失实验模型,加速糖尿病视网膜病变治疗药物的开发
  • 批准号:
    21K06604
  • 财政年份:
    2021
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A novel experimental model of chronic stress and hypertension for studying dementia-related neurovascular dysfunction in the hippocampus
用于研究海马痴呆相关神经血管功能障碍的新型慢性应激和高血压实验模型
  • 批准号:
    10194742
  • 财政年份:
    2021
  • 资助金额:
    $ 2.11万
  • 项目类别:
A novel experimental model of chronic stress and hypertension for studying dementia-related neurovascular dysfunction in the hippocampus
用于研究海马痴呆相关神经血管功能障碍的新型慢性应激和高血压实验模型
  • 批准号:
    10400211
  • 财政年份:
    2021
  • 资助金额:
    $ 2.11万
  • 项目类别:
Identifying adjunctive therapy in the experimental model of malaria to improve cerebral malaria outcomes
确定疟疾实验模型中的辅助治疗以改善脑型疟疾的结果
  • 批准号:
    10238203
  • 财政年份:
    2021
  • 资助金额:
    $ 2.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了